Update: 17.01.2023
Last week: 1 week 2023 (02.01.2023 - 08.01.2023)
Last full month: December 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 120 506 | -22.2% | 2.9% | 0.1 | 31 764 930 | -20.0% | 3.4% | 0.2 | -23.6% |
| MoM | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| YTD | 120 506 | -58.2% | 2.9% | -3.9 | 31 764 930 | -41.4% | 3.4% | -3 | -1.6% |
| MAT | 9 678 130 | -28.1% | 4.7% | -1.7 | 1 997 795 356 | -14.2% | 4.6% | -1.2 | -1.5% |
| DEXALGIN | |||||||||
| WoW | 18 168 | -16.6% | 0.4% | 0.1 | 9 672 047 | -12.0% | 1.5% | 0.2 | -26.1% |
| MoM | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| YTD | 18 168 | -54.4% | 0.4% | -0.5 | 9 672 047 | -38.1% | 1.5% | -1.1 | -6.3% |
| MAT | 1 563 877 | -15.5% | 0.6% | -0.1 | 680 733 495 | -3.5% | 1.7% | -0.3 | -0.1% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 40 316 | -21.5% | 39.4% | 0.4 | 24 752 266 | -20.9% | 49.1% | 0.9 | -22.3% |
| MoM | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| YTD | 40 316 | -57.7% | 39.4% | -24.4 | 24 752 266 | -46.1% | 49.1% | -21.5 | -31.4% |
| MAT | 4 229 168 | -20.2% | 52.7% | -13.2 | 2 187 435 011 | -10.3% | 58.5% | -12 | -0.1% |
| ESPUMISAN BABY | |||||||||
| WoW | 18 896 | -10.7% | 31.4% | 0.8 | 14 225 578 | -7.9% | 47.6% | 1.5 | -12.8% |
| MoM | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| YTD | 18 896 | -28.9% | 31.4% | -9.1 | 14 225 578 | -10.9% | 47.6% | -7.6 | -8.4% |
| MAT | 1 418 451 | -14.6% | 36.8% | -4.6 | 903 832 290 | -6.9% | 50.2% | -5.9 | -4.0% |
| FASTUM | |||||||||
| WoW | 14 078 | -6.4% | 1.0% | 0.1 | 8 523 862 | -0.6% | 2.7% | 0.5 | -18.6% |
| MoM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| YTD | 14 078 | -34.6% | 1.0% | -0.4 | 8 523 862 | -17.6% | 2.7% | -0.5 | -6.8% |
| MAT | 1 033 123 | -25.3% | 1.1% | -0.4 | 544 541 924 | -14.9% | 2.5% | -0.6 | -0.0% |
| IODOMARIN | |||||||||
| WoW | 42 130 | -27.3% | 20.4% | -1.2 | 7 807 327 | -26.8% | 7.4% | -0.7 | -23.1% |
| MoM | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| YTD | 42 130 | -19.4% | 20.4% | -1.8 | 7 807 327 | -18.9% | 7.4% | -2.3 | -12.3% |
| MAT | 3 283 241 | 3.1% | 20.5% | -0.2 | 638 173 582 | 7.2% | 9.0% | -0.4 | 3.9% |
| LIOTON | |||||||||
| WoW | 10 473 | -26.7% | 1.5% | -0.2 | 12 400 133 | -28.3% | 3.7% | -0.5 | -17.5% |
| MoM | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| YTD | 10 473 | -54.2% | 1.5% | -1.3 | 12 400 133 | -39.1% | 3.7% | -2.2 | -14.8% |
| MAT | 1 239 190 | -26.8% | 2.2% | -0.6 | 1 299 456 601 | -7.6% | 4.6% | -1 | -7.7% |
| MEZYM | |||||||||
| WoW | 225 091 | -24.7% | 21.2% | 0.1 | 34 102 869 | -22.1% | 14.5% | 0.8 | -25.2% |
| MoM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| YTD | 225 091 | -49.0% | 21.2% | -12.7 | 34 102 869 | -45.3% | 14.5% | -11.1 | -18.4% |
| MAT | 17 133 811 | -17.8% | 25.2% | -4 | 2 615 880 416 | -10.4% | 17.9% | -3.9 | -4.7% |
| MIG 400 | |||||||||
| WoW | 101 382 | -29.4% | 2.5% | -0.1 | 12 973 116 | -28.5% | 2.0% | -0.1 | -26.1% |
| MoM | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| YTD | 101 382 | -34.0% | 2.5% | -1 | 12 973 116 | -26.1% | 2.0% | -0.9 | -6.3% |
| MAT | 8 344 091 | -15.9% | 3.2% | -0.6 | 989 617 919 | -11.7% | 2.4% | -0.6 | -0.1% |
| PROSTAMOL | |||||||||
| WoW | 16 328 | -22.8% | 13.6% | 0.4 | 23 460 719 | -22.1% | 15.1% | 0.6 | -25.2% |
| MoM | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| YTD | 16 328 | -49.8% | 13.6% | -10.8 | 23 460 719 | -45.3% | 15.1% | -11.5 | -9.8% |
| MAT | 1 530 381 | -28.5% | 18.0% | -6.7 | 2 145 437 063 | -20.7% | 19.2% | -7.6 | -2.0% |
| RESPERO MYRTOL | |||||||||
| WoW | 22 136 | -30.6% | 7.6% | -0.7 | 12 348 268 | -28.3% | 8.7% | -0.6 | -24.4% |
| MoM | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
| YTD | 22 136 | -16.1% | 7.6% | -1.6 | 12 348 268 | 5.6% | 8.7% | 0 | 1.1% |
| MAT | 1 297 262 | 68.7% | 8.3% | 3.1 | 624 210 027 | 76.0% | 8.5% | 3 | 6.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 120 506 | -58.2% | 2.9% | -3.9 | 31 764 930 | -41.4% | 3.4% | -3 | -1.6% |
| DEXALGIN | 18 168 | -54.4% | 0.4% | -0.5 | 9 672 047 | -38.1% | 1.5% | -1.1 | -6.3% |
| ESPUMISAN (ADULTS) | 40 316 | -57.7% | 39.4% | -24.4 | 24 752 266 | -46.1% | 49.1% | -21.5 | -31.4% |
| ESPUMISAN BABY | 18 896 | -28.9% | 31.4% | -9.1 | 14 225 578 | -10.9% | 47.6% | -7.6 | -8.4% |
| FASTUM | 14 078 | -34.6% | 1.0% | -0.4 | 8 523 862 | -17.6% | 2.7% | -0.5 | -6.8% |
| IODOMARIN | 42 130 | -19.4% | 20.4% | -1.8 | 7 807 327 | -18.9% | 7.4% | -2.3 | -12.3% |
| LIOTON | 10 473 | -54.2% | 1.5% | -1.3 | 12 400 133 | -39.1% | 3.7% | -2.2 | -14.8% |
| MEZYM | 225 091 | -49.0% | 21.2% | -12.7 | 34 102 869 | -45.3% | 14.5% | -11.1 | -18.4% |
| MIG 400 | 101 382 | -34.0% | 2.5% | -1 | 12 973 116 | -26.1% | 2.0% | -0.9 | -6.3% |
| PROSTAMOL | 16 328 | -49.8% | 13.6% | -10.8 | 23 460 719 | -45.3% | 15.1% | -11.5 | -9.8% |
| RESPERO MYRTOL | 22 136 | -16.1% | 7.6% | -1.6 | 12 348 268 | 5.6% | 8.7% | 0 | 1.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 678 130 | -28.1% | 4.7% | -1.7 | 1 997 795 356 | -14.2% | 4.6% | -1.2 | -1.5% |
| DEXALGIN | 1 563 877 | -15.5% | 0.6% | -0.1 | 680 733 495 | -3.5% | 1.7% | -0.3 | -0.1% |
| ESPUMISAN (ADULTS) | 4 229 168 | -20.2% | 52.7% | -13.2 | 2 187 435 011 | -10.3% | 58.5% | -12 | -0.1% |
| ESPUMISAN BABY | 1 418 451 | -14.6% | 36.8% | -4.6 | 903 832 290 | -6.9% | 50.2% | -5.9 | -4.0% |
| FASTUM | 1 033 123 | -25.3% | 1.1% | -0.4 | 544 541 924 | -14.9% | 2.5% | -0.6 | -0.0% |
| IODOMARIN | 3 283 241 | 3.1% | 20.5% | -0.2 | 638 173 582 | 7.2% | 9.0% | -0.4 | 3.9% |
| LIOTON | 1 239 190 | -26.8% | 2.2% | -0.6 | 1 299 456 601 | -7.6% | 4.6% | -1 | -7.7% |
| MEZYM | 17 133 811 | -17.8% | 25.2% | -4 | 2 615 880 416 | -10.4% | 17.9% | -3.9 | -4.7% |
| MIG 400 | 8 344 091 | -15.9% | 3.2% | -0.6 | 989 617 919 | -11.7% | 2.4% | -0.6 | -0.1% |
| PROSTAMOL | 1 530 381 | -28.5% | 18.0% | -6.7 | 2 145 437 063 | -20.7% | 19.2% | -7.6 | -2.0% |
| RESPERO MYRTOL | 1 297 262 | 68.7% | 8.3% | 3.1 | 624 210 027 | 76.0% | 8.5% | 3 | 6.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 120 506 | -22.2% | 2.9% | 0.1 | 31 764 930 | -20.0% | 3.4% | 0.2 | -23.6% |
| DEXALGIN | 18 168 | -16.6% | 0.4% | 0.1 | 9 672 047 | -12.0% | 1.5% | 0.2 | -26.1% |
| ESPUMISAN (ADULTS) | 40 316 | -21.5% | 39.4% | 0.4 | 24 752 266 | -20.9% | 49.1% | 0.9 | -22.3% |
| ESPUMISAN BABY | 18 896 | -10.7% | 31.4% | 0.8 | 14 225 578 | -7.9% | 47.6% | 1.5 | -12.8% |
| FASTUM | 14 078 | -6.4% | 1.0% | 0.1 | 8 523 862 | -0.6% | 2.7% | 0.5 | -18.6% |
| IODOMARIN | 42 130 | -27.3% | 20.4% | -1.2 | 7 807 327 | -26.8% | 7.4% | -0.7 | -23.1% |
| LIOTON | 10 473 | -26.7% | 1.5% | -0.2 | 12 400 133 | -28.3% | 3.7% | -0.5 | -17.5% |
| MEZYM | 225 091 | -24.7% | 21.2% | 0.1 | 34 102 869 | -22.1% | 14.5% | 0.8 | -25.2% |
| MIG 400 | 101 382 | -29.4% | 2.5% | -0.1 | 12 973 116 | -28.5% | 2.0% | -0.1 | -26.1% |
| PROSTAMOL | 16 328 | -22.8% | 13.6% | 0.4 | 23 460 719 | -22.1% | 15.1% | 0.6 | -25.2% |
| RESPERO MYRTOL | 22 136 | -30.6% | 7.6% | -0.7 | 12 348 268 | -28.3% | 8.7% | -0.6 | -24.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| DEXALGIN | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| ESPUMISAN (ADULTS) | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| ESPUMISAN BABY | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| FASTUM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| IODOMARIN | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| LIOTON | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| MEZYM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| MIG 400 | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| PROSTAMOL | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| RESPERO MYRTOL | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs